In this video, Fool.com analysts David Williamson and Max Macaluso discuss United Therapeutics and Discovery Laboratories' 15% intraday plunges. One received an FDA rejection and the other had a familiar problem rear its ugly head. Watch and find out what this means for these stocks, their competitors, and investors.
